Summary. The effect of blood-glucose lowering biguanides (phenethyl-and butylbiguanide) on active intestinal transport of different amine acids has been tested in hamster small intestine in vitro. --. Biguanides inhibited active transport of all amino acids tested. The inhibitory effect of biguanides increased with incubation time, was more pronounced after preincubation of intestinal tissue and was found to be non-competitive. The minimal inhibitory concentration of phenethylbiguanide on amino acid transport was 5 • 1() -4 M. --l~C-butylbiguanide was found to be transported into hamster small intestine by a concentration-independent, energy-lndependent uptake mechanism and was accumulated in intestinal tissue against a concentration gradient. --In accord with earlier results on the inhibitory effect of biguanides on active intestinal hexose transport it is concluded that biguanides do net act as specific inhibitors for glucose transport, but rather affect active, energy-requiring intestinal transport mechanisms in general (hexese-, amino acid-, calcium-and myo-inositel transport), most likely due to their known inhibitory effect on mitochendrial respiration, thus depriving mucosal cells of ATP required to translocate substrates against a concentration gradient.
Introduction
Evidence that biguanldes are inhibiting or delaying glucose kbsorption from the intestine has been reported by several investigators [3, 4, 7, 8, 14, 20, 21, 23, 24] . The in vitro effect of blood sugar lowering biguanides on active transport of several substrates for the common Na+-dependent active sugar transport system can be explained by inhibition of active transport of hexoses [7] . Transport of substrates having a high affinity for the transport system (D-glucose, D-galactose) was more strongly inhibited by biguanides than transport of low affinity substrates [7] , whereas uptake of D-fructose which i~ not a substrate for the common Na+-depcndent sugar pathway was not affected [7] .
Transport of amino acids in hamster small int4stine exhibits similar features to sugar transport, namely: energy-dependence, saturation transport kinetics, accumulation against a concentration gradient, Na +-dependency [13, 25] . The purpose of our present study was to find out whether biguanides inhibit transport of actively transported sugars only, thus having a specific effect on sugar absorption, or inhibit, also, active intestinal transport of amino acids using the different amino acid transport pathways [25] . If the latter were true one could assume that biguanides affect active transport processes per so, possibly by depriving the mucosal epithelial cell of energy required to translocate substrates against a concentration * Part of this work has been presented at the International Diabetes Congress, Buenos Aires, Argentina, August 1970 and at the Meeting of German and Italian Pharmacology Society, Heidelberg, September 1970.
gradient. This would be a ~ery likely possibility since biguanides are known to be strong inhibitors of mitochondrial respiration [16] . Since myo-inositol, structurally very similar to D-glucose, is actively transported in the intestine by an entry mechanism different from the common hexose pathway [6] , the effect of biguanldes on transport of myo-inositol was also tested.
Methods
The present experiments were performed by the in vitro method of Crane and Mandelstam [10] as modified i~ a more recent publication [5] . Hamsters, of 80 -{-15 g weight were fasted overnight. Approximately 200--300 g, wet weight, of everted segments of small intestine were placed in 25 ml Erlenmeyer flasks, containing 5 or 10 ml of Krebs-Henseleit phosphate buffer with the appropriate substrates added. The buffer was gslssed with pure oxygen and incubations carried out in a Dubnoff shaking water bath (37~ for the time indicated in the graphs. D-mannitol was used as a marker of extracellular space [5, 9] . In preincubation experiment~ intestinal tissue was incubated either in bmCfer alone or in buffer with different concentrations of biguanides for the time indicated in the graphs, rem.oved from the flasks, rinsed for 15 see with buffer and transferred to a new medium containing substrates without biguanides.
Compounds
Amino acids and myo-inositol were obtained from Sigma (St. Louis, Miss., USA) and were of analytical grade, which was confirmed by chromatography with different solvent systems. Phenethylbiguanide-hydrochloride was obtained from USV Pharmaceutical Corporation (New York), butylbiguanide-hydrochloride from Chemic Griinenthal (Stolbcrg/Rheinland, Germany), methylbiguanide from Dr. Heinz Haury (Miinchen). 1~-C-'butyl-biguanide (spec. activity 11.4 ~tCi/mg) was a gift from Dr. R. Beckmann (Chemie Grtinenthal, Stolberg/ ~heinland, Germany). Labelled compounds ((U)-14C-Llcucine, z*C-L-methionine, x*C-L-lysine, ~4C-L-glycine, 14C-L-proline, 14C-~-aminoisobutrie acid ,3H-myo-inositol, 3H and 14C-D-marmitol) were obtained from New England Nuclear or Amersham.
Analytical method
Incubations were terminated by removal of the tissue which then was processed as described by Crane and Mandelstam [ 10] . Radioactivity of the medium and tissue water extracts was assayed with a Packard Liquid Scintillation System using the channel ratio method for quench -correction.
Calculation of data
Results are expressed in: ~tmoles/ml tissue water per cent filling = 100 • ~tmoles/ml initial medium or in ~zmoles/ml tissue water per unit time in kinetic experiments to express velocity of substrate uptake [5] . A figure > 100 means accumulation of the substrate in the tissue water space compared to the medium substrate concentration.
The data are corrected for extracellular space [9] . Results are given as means 5: S. E. M.
After incubation with the various labelled compounds tissue water extracts and incubation medium were subjected to paper chromatography using different solvent systems, l~Iore thart 94~/o of the radioactivity of tissue water extracts was found in one peak, corresponding to the reference substrato (before incubation) when subjected to a Packard autoscanner and subsequent counting of the peak with a Liquid Scintillation System. This indicated that there were no appreciable amounts of metabolic products of the substrates used to measure transport into intestinal tissue.
Results
Since the inhibitory effect of biguanides on active sugar transport could be observed only after a minimum exposure of 5 rain to biguanides [7] we studied the time-dependence of the inhibitory effect of biguanides on active in vitro transport of L-methionine, which is translocated in the intestine across the brush border membrane by the Na+-dependent active neutral amino acid transport system [25] . A significant inhibitory effect of phenethylbiguanide on uptake of L-methion. ine could be observed already after 5 rain of in'cubation, when substrate and inhibitor were present simultaneously in the incubation medium. This effect was even more pronounced after 10 and 30 min of incubation (Fig. 1) . Chromatographic examination of the tissue water extracts revealed that 95% of the radioactivity was unmetabolized L-methionine.
In order to find out whether biguanides might exert their inhibitory action from the mucosal side of the membrane only, possibly by competing with amino acids for a common carrier binding site, we prcincubated intestinal tissue with phenethylbiguanide for 15 min, rinsed the tissue thoroughly for 30 sec with buffer and transferred the tissue to a new incubation medium containing the substrate (L-methionine) without phenethylbiguanide. Under these conditions inhibition of L-methionine uptake could be observed earlier ( Fig. 2 ) and was more pronounced at 10 rain of incubation compared to the first experiment ( Fig. 1 ) where substrate and inhibitor were added simultane- [i ] In these experiments intestinal tissue was preincubated with different concentrations of phenethylbiguanide, but similar results were obtained when substrates (Lproline and L-lysine) and inlfibitor were added simultaneously and the incubations carried out for 45 min, thus allowing the biguanide to achieve an intracellular concentration high enough to exert its inhibitory effect (Fig. 4) .
Butylbiguanide exhibited a similar inhibitory effect on uptake of amino acids (L-leucine, L-methionine, glycine and :r acid) (Fig. 5 ) compared with phenethylbiguanide. The concentration of butylbiguanide required to achieve an equal inhibitory effect to 10-2M phenethylbiguanide was 2 • 10-2M. The time-dependent inhibitory effect of butylbiguanide on transport of L-leucine was equal to that of phenethylbiguanide. A significant inhibitory effect of both biguanides could be observed after 5 rain of incubation (Fig. 6) .
In order to demonstrate that phenethylbiguanide is also able to inhibit uptake of higher substrate concentrations, as was to be expected from a non-competitive type of inhibition, intestinal tissue was incubated with several amino acids at concentrations far below and far above their transport Kin-values (Table 2). Upake of L-proline, L-methionine, glyeine, ~-aminoisobutyric acid, L-leueine, and L-lysine was inhibited by phenethylbiguanidc if the substrates were present at concentrations of 30m~I in the incubation medium. Active transport of myo-inositol is inhibited, too, by phenethylbiguanide.
In order to find out whether biguanides do exert their inhibitory effect by binding to the mucosal surface or after entry into the mucosal cells we measured tissue uptake of 14C-butylbiguanide. After 60 rain of incubation butylbiguanide was accumulated against a concentration gradient (Fig. 7) . Uptake was linear up to an incubation time of 20 min. Accumulation of a substrate against a concentration gradient docs, however, not necessarily mean that an active transport mechanism is involved. The uncoupling agent 2.4-d'initrophenol, known to be a strong inhibitor of active transport processes, did not affect tissue uptake of butylbiguanide (Table 3) . Addition of high concentrations of phenethylbiguanide and cold butylbiguanide to tracer concentrations of 14C-butylbiguanide did not affect uptake of 14C-butylbiguanide; these findings are consistent with a diffusional, energy-independent uptake mechanism for butylbiguanide in the intestine. An inhibitory effect on uptake of butylbiguanide was, however, observed in the presence of ouabain (Table 3) . Rinsing of tissue incubated with 14C-butylbiguanide removed the amount of butylbiguanide located in the extracellular space, but did not affect intracellular concentrations of 14C-butylbiguanide. The fact that with increasing incubation time more butylbiguanide can be found in the tissue suggcsts entry of the sub~trate into the cells rather than surface binding.
Discussion
Active transport of amino acids known to be transported across the intestinal brush border membrane by different transport systems was markedly inhibited in the presence of blood sugar lowering biguanides. This inhibitory effect was even more pronounced if intestinal tissue was prcexposed to biguanides and subsequently incubated with the appropriate substrates. These findings might be explained by the rather slow rate of entry of biguanidcs (demonstrated active, energy-requiring transport systems in general. This is further confirmed by the observation that active transport of myo-inositol --a compound structurally very similar to. D-glucose, but having different carrier binding sites from D-glucose [6] --is also inhibited by phenethylbiguanide. Active intestinal transport of calcium is inhibited by biguanides, too [8] .
Recent studies by Robinson [24] have shown that active transport of sugars and amino acids was inhibited by biguanide~ in dog small intestine and in clog kidney cortex slices. Robinson suggests that biguan- (Fig. 7) and suggests that biguanides do exert their inhibitory effect from inside the tissue rather than at the mucosal surface. The inhibitory effect of biguanides on glucose absorption observed by many investigators [3, 4, 7, 8, 14, 20, 23, 24] seems, according to our results, not specific for the active sugar transport system. The results presented, in addition to earlier observations [8, 24] , suggest that biguanides rather seem to affect 
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ides might, at least in the kidney, act through an inhibition of the second (ethacrynie acid-sensitive) sodium pump. As ATP-levels in the mucosal tissue have been found to be decreased after exposure of the intestine to biguanides [23] , it seems, however, more likely that the inhibitory effect of biguanides on all energy-requiring transport processes in the intestine results from the known inhibitory effect of biguanides on mitochondrial respiration [16] . The slow onset of hexose [7] and amino acid transport inhibition in the intestine by biguanides and the more pronounced inhibitory effect after preincubation of the tissue with biguanides suggests that the dings either act by an irreversible binding to the hexose or amino acid carrier sites or by entering the absorbing cells and acting from inside, possibly by competing with potassium for entry into the mitochondria and thus inhibiting mitochondrim respiration, as suggested by Davidoff [16] . Inhibition of respiration would then lead to a deprivation of energy requfi'ed for translocation of actively transported solutes across the brush border membrane. The fact that biguanides did exert a stronger inhibitory effect on transport of amino acids from the cell interior than from the luminal side does not support an assumption of a Na+-substrate-carrier interaction. If biguanides act as competitive reversible inhibitors binding to the carrier-substrate recognition site, like the action of phlorizin on active glucose transport [1] , it should have been possible to wash off the inhibitory effect of phenethylbiguanide, or higher substrate concentrations should have been able to overcome the inhibitory effect of biguanides exerted on low substrate concentrations. Rinsing of intestinal tissue which was loaded with biguanides did not abolish or diminish the inhibitory effect of biguanides on tissue uptake of L-methiouine (Fig. 2) . Our data on the entry mechanism of biguanides into the mucosal epithelial cell suggests that uptake of butylbiguanide across the brush border membrane occurs through a diffusional mechanism with final distribution ratios achieving more than unity. Davidoff [16] reported that phenethylbiguanide achieved concentration gradients up to 100:1 in guinea pig heart mitochondria, but initial uptake rates of phenethylbiguanide into mitochondria did not give evidence for a saturating transport process using 10S-fold different concentrations of phenethylbiguanide [16] . ~Vhether these concentration ratios are determined by transmembrane pH-gradients or rather by transmembrahe electrical potential differences cannot be decided. The inhibitory effect of ouabain on tissue uptake of butylbiguanide suggests that uptake of biguanides may be, at least in part, affected by the action of the sodium pump. Uptake of butylbiguanide was, however, not energy-dependent.
Studies in humans using the segmental intestinal perfusion technique have shown an inhibition of glucose absorption after pretreatment of patients with therapeutic doses of biguanides [3, 23] . The inhibitory effect of phenethylbiguanide in one study [3] was more than 50~/o and also showed an inhibition of water absorption from the intestine in humans. This means at least a delay of glucose absorption from the intestine will occur in patients treated with biguanides resulting in a decreased insulin response after an oral glucose load [19] . This effect may be even more potentiated after a mcal than after intraduodenal application of the glucose load, for biguanides arc known to inhibit gastric emptying [i 1, 22] in addition to their inhibitory effect on glucose absorption. Comparing the in vitro inhibitory effect of biguanides on active transport of hexoscs [7] with the present data on the influence of biguanides on active transport of amino acids in vitro, it can be suggested thal~ amino acid absorption may be inhibitcd also in vivo after pretreatment with therapeutic doses of biguanides. As many amino acids are known to be strong stimulators of insulin secretion [18] a delay of intestinal amino acid absorption after pretreatment with biguanides may contribute to the lower insulin levels observed in patients on biguanide-treatment [2] . This assumption is supported by the observation of Czyzyk and coworkers [15] . They found decreased insulin and decreased a-amino-nitrogen levels in the peripheral blood after an intraduodenal load of amino acids in patients pretreated with phenethylbiguanide. This effect might be explained by a delay of intestinal amino acid absorption after treatment with biguanides. As biguanides were shown to act as non-competitive inhibitors on amino acid uptake rates, affecting maximal transport capacity (Vmax) rather than Km of the transported solutes (Fig. 3) , the inhibitory effect can be demonstrated at low and at high substrate concentrations (Table 2) . Thus higher substrate concentrations cannot overcome the inhibitory effect exerted by biguanides.
The concentrations of biguanides used in our studies ranged from 5 )< 10-4M to 10-2M. Such concentrations will never be achieved in the peripheral tissues after therapeutic doses of biguanides [12] . It is known, however, that the highest local concentrations of biguanides occur in the liver and the intestine [26] . An accumulation of the drug against a gradient can be sho~ul in the small intestine in vitro (Fig. 7) . As uptake of butylbiguanide did not show a saturation phenomenon, intracellular accumulations in the intestine may be even higher than the concentration of .biguanides in the intestinal lumen. If a 100 mg fabler"is diluted by 500 ml. of intestinal juice, the concentration of butylbiguanide in the lumen will be about 1 mM and intraeellular concentrations' in the mucosa may be even higher. Thus after an oral therapeutic dose of biguanides concentrations will be achieved in the intestine which exerted, in our in vitro system, an inhibitory effect on amino acid transport.
From the results reported in the literature [3, 4, 7, 8, 14, 20, 21, 23, 24] and the data presented in this paper it can be concluded that biguanides do inhibit several active, energy-requiring intestinal transport mechanisms, resulting in "an inhibition or delay Of intestinal nutrient absorption in vivo. If and how much this inhibitory effect participates in the blood ghicose lowering effect of these oral antidiabetic drugs in diabetics can not yet be decided.
